Suchergebnisse - "Kurti, Zsuzsanna"

PubPharm (65)

1

Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2019

von Ilias, A. | Szanto, K. | Gonczi, L. | +10

2

High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance

enthalten in: Journal of Crohn's & colitis | 2019

von Singh, K. | Al Khoury, A. | Kurti, Z. | +10

3

Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype : A Prospective Study in a High-volume IBD Centre

enthalten in: Journal of Crohn's & colitis | 2019

von Gonczi, L. | Kurti, Z. | Verdon, C. | +10

4

Harmonization of quality of care in an IBD center impacts disease outcomes : Importance of structure, process indicators and rapid access clinic

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2019

von Reinglas, J. | Restellini, S. | Gonczi, L. | +10

5

The role of fecal calprotectin in the diagnosis and treatment of gastrointestinal diseases

enthalten in: Orvosi hetilap | 2019

von Iliás, �. | Rózsa, F. | Gönczi, L. | +3

6

Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2019

von Rencz, F. | Lakatos, P. | Gulácsi, L. | +9

7

Biosimilars in IBD : Will it Benefit to Patients, Physicians or the Health Care System?

enthalten in: Current pharmaceutical design | 2019

von Gonczi, L. | Ilias, A. | Kurti, Z. | +1

8

Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease

Erschienen: 2019

von Rencz, F. | Lakatos, P. | Gulácsi, L. | +9

9

Biosimilars in IBD: Will it Benefit to Patients, Physicians or the Health Care System?

enthalten in: Current pharmaceutical design | 2019

von Gonczi, L. | Ilias, A. | Kurti, Z. | +1

10

Optimizing Patient Management in Crohn's Disease in a Tertiary Referral Center : the Impact of Fast-Track MRI on Patient Management and Outcomes

enthalten in: Journal of gastrointestinal and liver diseases : JGLD | 2018

von Ilias, A. | Lovasz, B. | Gonczi, L. | +6

CommentIn: J Gastrointestin Liver Dis. 2019 Mar;28(1):130-131. - PMID 30851184

1
2
3
4
5
6
7
Nächster »
[7]